{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:05Z","timestamp":1761895265968},"reference-count":26,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.3109\/10428194.2011.559670","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T10:22:32Z","timestamp":1303294952000},"page":"1010-1016","source":"Crossref","is-referenced-by-count":4,"title":["Does pretreatment fluorescence<i>in situ<\/i>hybridization for<i>BCR\u2013ABL<\/i>predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?"],"prefix":"10.1080","volume":"52","author":[{"given":"Lisa M.","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keeran","family":"Sampat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarit","family":"Assouline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Saxe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharron","family":"Nault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourad","family":"Tighiouart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Mclemore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott","family":"Winton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Bernal-Mizrachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Jean Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,4,20]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.38"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8154"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11863"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1928"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-161737"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102061"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441401"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020461"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.4452"},{"key":"CIT0012","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE), version 3.0 [Internet]. 9 August 2006. Available from: http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1199"},{"key":"CIT0014","unstructured":"NCCN Practice Guidelines in Oncology, v. 1.2009 [Internet]. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/cml.pdf"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17098-0"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-103499"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0025"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3800"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3530"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.03.029"},{"issue":"18","key":"CIT0022","volume":"25","author":"Hamdan MY","year":"2007","journal-title":"J Clin Oncol"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.99.209"},{"issue":"15","key":"CIT0024","volume":"26","author":"Khoury HJ","year":"2008","journal-title":"J Clin Oncol"},{"issue":"18","key":"CIT0025","volume":"25","author":"Jabbour E","year":"2007","journal-title":"J Clin Oncol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3724"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2011.559670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T16:14:35Z","timestamp":1481818475000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2011.559670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,20]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,5,23]]},"published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.3109\/10428194.2011.559670"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2011.559670","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,20]]}}}